Projects per year
Fingerprint
Dive into the research topics where Richard M Weinshilboum is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Alcohol Use Disorder: Acamprosate Pharmacometabolomics-informed Pharmacogenomics
Project: Research project
-
ADMINISTRATIVE CORE
Jiawei, H., Sinha, S., Song, J., Weinshilboum, R. M. & Weinshilboum, R. M.
9/29/14 → 4/30/18
Project: Research project
-
-
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia
Weinshilboum, R. M. & Kinney, L.
8/1/08 → 5/31/14
Project: Research project
-
Research Output
-
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes
The Mood Disorders Precision Medicine Consortium (MDPMC), Mar 1 2020, In : Journal of Affective Disorders. 264, p. 90-97 8 p.Research output: Contribution to journal › Article
Open Access1 Scopus citations -
Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor
Ingle, J. N., Cairns, J., Suman, V. J., Shepherd, L. E., Fasching, P. A., Hoskin, T. L., Singh, R. J., Desta, Z., Kalari, K. R., Ellis, M. J., Goss, P. E., Chen, B. E., Volz, B., Barman, P., Carlson, E. E., Haddad, T., Goetz, M. P., Goodnature, B., Cuellar, M. E., Walters, M. A. & 4 others, , Jun 15 2020, In : Clinical Cancer Research. 26, 12, p. 2986-2996 11 p.Research output: Contribution to journal › Article
Open Access2 Scopus citations -
Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1 (Cell Research, (2020), 30, 7, (590-601), 10.1038/s41422-020-0315-8)
Yu, J., Qin, B., Moyer, A. M., Nowsheen, S., Tu, X., Dong, H., Boughey, J. C., Goetz, M. P., Weinshilboum, R., Lou, Z. & Wang, L., Sep 1 2020, In : Cell Research. 30, 9, p. 823 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol)
Bielinski, S. J., St Sauver, J. L., Olson, J. E., Larson, N. B., Black, J. L., Scherer, S. E., Bernard, M. E., Boerwinkle, E., Borah, B. J., Caraballo, P. J., Curry, T. B., Doddapaneni, H. V., Formea, C. M., Freimuth, R. R., Gibbs, R. A., Giri, J., Hathcock, M. A., Hu, J., Jacobson, D. J., Jones, L. A. & 28 others, , Feb 1 2020, In : International journal of epidemiology. 49, 1, p. 23-24KResearch output: Contribution to journal › Article
6 Scopus citations -
Comparing outcomes and costs among warfarin-sensitive patients versus warfarininsensitive patients using the Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort
Swanson, K. M., Zhu, Y., Rojas, R. L., St. Sauver, J. L., Bielinski, S. J., Jacobsen, D. J., Visscher, S. L., Wang, L., Weinshilboum, R. & Borah, B. J., May 2020, In : PloS one. 15, 5, e0233316.Research output: Contribution to journal › Article
Open Access1 Scopus citations